Stockscreener 앱 받기
12.32
4.10%
0.485
시간 외 거래:
12.25
-0.075
-0.61%
전일 마감가:
$11.84
열려 있는:
$11.69
하루 거래량:
1.39M
Relative Volume:
1.19
시가총액:
$958.55M
수익:
$1.64B
순이익/손실:
$-495.80M
주가수익비율:
-1.9246
EPS:
-6.404
순현금흐름:
$-45.25M
1주 성능:
-8.91%
1개월 성능:
-23.06%
6개월 성능:
+14.65%
1년 성능:
-20.28%
1일 변동 폭
$11.66
$12.36
1주일 범위
$11.57
$13.83
52주 변동 폭
$8.70
$20.49
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
명칭
Integra Lifesciences Holdings Corp
전화
(609) 275-0500
주소
1100 CAMPUS ROAD, PRINCETON, NJ
Compare IART vs ABT, MDT, SYK, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IART
Integra Lifesciences Holdings Corp
|
12.32 | 958.55M | 1.64B | -495.80M | -45.25M | -6.404 |
ABT
Abbott Laboratories
|
102.51 | 177.38B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
96.59 | 123.55B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
307.08 | 117.79B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
46.01 | 66.68B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.09 | 51.93B | 6.30B | 1.07B | 1.09B | 1.8406 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-07-28 | 개시 | UBS | Neutral |
| 2026-07-09 | 개시 | BMO Capital Markets | Market Perform |
| 2026-06-18 | 업그레이드 | Argus | Hold → Buy |
| 2026-05-28 | 업그레이드 | Citigroup | Sell → Neutral |
| 2026-04-15 | 다운그레이드 | Argus | Buy → Hold |
| 2025-03-31 | 업그레이드 | Argus | Hold → Buy |
| 2024-12-02 | 개시 | Morgan Stanley | Underweight |
| 2024-10-07 | 업그레이드 | BTIG Research | Sell → Neutral |
| 2024-07-30 | 다운그레이드 | BTIG Research | Neutral → Sell |
| 2024-07-30 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2024-05-07 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-05-07 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-04-03 | 업그레이드 | Citigroup | Sell → Neutral |
| 2023-12-05 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-11-14 | 개시 | CL King | Buy |
| 2023-08-24 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2023-07-12 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-08 | 다운그레이드 | Argus | Buy → Hold |
| 2023-05-24 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-05-23 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-07-25 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-04-13 | 다운그레이드 | Truist | Buy → Hold |
| 2021-12-17 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2021-09-15 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2020-10-08 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2020-05-27 | 개시 | Citigroup | Neutral |
| 2020-04-03 | 개시 | SunTrust | Buy |
| 2020-01-07 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2019-01-03 | 개시 | SunTrust | Buy |
| 2018-11-28 | 개시 | UBS | Neutral |
| 2018-08-07 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-07-26 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2018-07-02 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2018-01-05 | 재개 | Cantor Fitzgerald | Neutral |
| 2018-01-02 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2017-11-09 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-10-30 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2017-10-27 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2017-06-30 | 개시 | Cantor Fitzgerald | Overweight |
| 2017-05-02 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-01-13 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-01-06 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
| 2016-12-12 | 개시 | UBS | Buy |
모두보기
Integra Lifesciences Holdings Corp 주식(IART)의 최신 뉴스
Integra: 3 Key Takeaways for Long-Term Investors - The Motley Fool
Integra LifeSciences (IART) Surpasses Q3 Earnings Estimates - Zacks Investment Research
Integra LifeSciences Reports Third Quarter 2026 Financial Results - GlobeNewswire Inc.
Precision Trading with Integra Lifesciences Holdings Corporation (IART) Risk Zones - Stock Traders Daily
Integra Announces Completion of Refinancing Transactions - GlobeNewswire
Press Release Distribution & Media Outreach Platform for PR Agencies - ACCESS Newswire
Will Flood Driven Guidance Cut Change Integra LifeSciences Stock Narrative - Simply Wall Street
Integra LifeSciences Holdings (IART) Prices 9.5% Notes, Is The Repair Story Still Undervalued? - Simply Wall Street
Integra LifeSciences to Showcase ENT Portfolio and Support New Clinical Research at AAO-HNSF Annual Meeting - Quiver Quantitative
Integra LifeSciences to Highlight ENT and Instruments - GlobeNewswire
New research on balloon treatment alongside surgery for chronic ear disease will be presented - Stock Titan
Truist cuts target for Integra LifeSciences stock to USD 15.00 - ad-hoc-news.de
Press Release Distribution & Media Outreach Platform for PR Agencies - ACCESS Newswire
Truist Securities Adjusts Integra LifeSciences Price Target to $15 From $19 - Yahoo Finance
INTEGRA LIFESCIENCES HOLDINGS CORPORATION IART INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 21.2% Share Drop - Business Wire
Integra LifeSciences (IART) 10K Form and Latest SEC Filings 2026 - MarketBeat
Integra Lifesciences Holdings Corp (IART) Shares Surge 4.0% -- W - GuruFocus
What Is Integra LifeSciences Holdings (IART) $450 Million Debt Deal Changing? - Simply Wall Street
Integra LifeSciences Holdings Corporation at Morgan Stanley Global Healthcare Conference Transcript - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Encourages Integra LifeSciences Holdings Corporation (IART) Investors to Inquire about Securities Investigation - ACCESS Newswire
Integra LifeSciences (IART) Prices $450M Senior Secured Notes Ma - GuruFocus
Integra LifeSciences prices $450M senior secured notes at 9.5% - Investing.com
Integra LifeSciences Prices $450 Million of 9.500% Senior Secured Notes Due 2033 - Quiver Quantitative
Integra Announces Pricing of Senior Secured Notes - GlobeNewswire
$450 million in Integra LifeSciences notes carry a 9.5% rate - Stock Titan
Integra LifeSciences Holdings (IART) Resets Guidance As The Undervalued Narrative Faces A Fresh Test - Simply Wall Street
A Look at Integra Lifesciences Holdings Corp (IART) After 3.1% G - GuruFocus
Integra LifeSciences Holdings (IART) Cuts 2026 Revenue Outlook, Is The Stock Below Fair Value? - Yahoo Finance
Wells Fargo cut its target for Integra LifeSciences stock to USD 15.00 - AD HOC NEWS
Integra LifeSciences stock cuts guidance after Cincinnati flooding - AD HOC NEWS
BMO cuts target for Integra LifeSciences stock to USD 15 - AD HOC NEWS
INTEGRA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
Integra LifeSciences to Host Third Quarter 2026 Financial Results Conference Call on October 21, 2026 - GlobeNewswire
Integra LifeSciences to Host Third Quarter 2026 Financial Results Conference Call on October 21, 2026 - GlobeNewswire
How Investors Are Reacting To Integra LifeSciences Holdings (IART) Full Year Revenue Cut - Simply Wall Street
Integra LifeSciences to Host Third Quarter 2026 Financial Results Conference Call on October 21, 2026 - Yahoo Finance
INTEGRA LIFESCIENCES HOLDINGS CORPORATION INVESTIGATION: - GlobeNewswire
Flood Damage Prompts Integra LifeSciences To Revise 2026 Outlook - Benzinga
BMO cuts Integra LifeSciences stock price target on facility disruption - Investing.com
Integra LifeSciences (NASDAQ: IART) Investor Alert: Johnson - GlobeNewswire
Wells Fargo cuts Integra LifeSciences price target on lower revenue outlook - Investing.com
Is Integra Lifesciences Holdings Corp (IART) a Bargain After 21. - GuruFocus
Why Integra LifeSciences (IART) Stock Is Nosediving - Yahoo Finance
Integra LifeSciences (IART) Shares Plunge Nearly 21% Following Q - GuruFocus
Integra LifeSciences plunges 21% on preliminary Q3 results (IART:NASDAQ) - Seeking Alpha
Integra LifeSciences Q3FY26 Results: Guidance cut on flood impact - scanx.trade
Stock Market Midday, Oct. 2: Stocks Rally as Weak Jobs Data Cools Fed Rate Hike Bets - The Motley Fool
Integra LifeSciences Holdings Corporation Announces Launch Of $600 Million Senior Secured Term Loan B - marketscreener.com
Why is Integra LifeSciences stock tumbling today? - Investing.com
Integra LifeSciences stock tumbles after cutting 2026 outlook - Investing.com
Integra Lifesciences Holdings Corp (IART) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Integra Lifesciences Holdings Corp 주식 (IART) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL |
Mar 10 '26 |
Option Exercise |
0.00 |
1,216 |
0 |
23,152 |
| Poul Mojdeh | President & CEO |
Jan 06 '26 |
Option Exercise |
0.00 |
1,390 |
0 |
1,390 |
| GRAVES JEFFREY A | Director |
Nov 05 '25 |
Buy |
11.35 |
9,000 |
102,150 |
41,086 |
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL |
Oct 12 '25 |
Option Exercise |
0.00 |
11,965 |
0 |
25,217 |
3.55%
4.26%
자본화:
|
볼륨(24시간):